2010 JBS/SBS Academic Excellence Awards

tuoping luo,nathan t ross,andrew m stern,stuart l schreiber,g krishnamoorthy

DOI: https://doi.org/10.1177/1087057110390634

2010-01-01

Journal of Biomolecular Screening

Abstract:New Small Molecule Tools for Studying Mitochondrial Protein Translocation Samuel A. Hasson, Graduate Student, Koehler Lab, UCLA Department of Chemistry and Biochemistry The mitochondrion is the center for oxidative metabolism and metabolite biosynthetic pathways. Additionally, growing evidence of mitochondrial dysfunction as a major contributor to human disease has made it an attractive drug target. Even though the mitochondrion contains its own small genome that codes for a handful of proteins, most of the mitochondrial proteome is encoded in the nuclear genome and imported from the cytosol. The TIM23 translocation pathway handles proteins with a typical N-terminal targeting sequence, and the TIM22 translocation pathway mediates import of inner membrane proteins. Both of these translocation pathways are highly conserved from yeast to mammals. Our lab has previously characterized mitochondrial biogenesis using classical yeast genetics and biochemical assays with purified mitochondria. However, new strategies are needed to elucidate the detailed mechanisms of mitochondrial protein translocation and their role in mammalian development and human disease. To this end, we have utilized chemical genetics to identify novel compounds that modulate protein translocation. Yeast harboring mutations in their TIM22 translocon were adapted to a simple, high-throughput screen based on chemicalsynthetic lethality. From a collection of over 50,000 drug-like small molecules, 2 have been identified that target mitochondrial protein import pathways. MitoBloCK-1 specifically impaired protein transit through the TIM22 translocon and was synthetic lethal with pathway mutants in vivo. Using an in vitro import assay, MitoBloCK-1 directly abrogated the import of inner membrane proteins but did not alter the mitochondrial membrane potential. A second compound, MitoBloCK-3, was identified to be a novel class of thiol-reactive molecules. This compound Journal of Biomolecular Screening 15(10); 2010 DOI: 10.1177/1087057110390634 2010 JBS/SBS Academic Excellence Awards 2010 JBS/SBS Academic Excellence Awards 2010 JBS/SBS Academic Excellence Awards 1290 www.sbsonline.org Journal of Biomolecular Screening 15(10); 2010 demonstrated a preferential inhibition of protein import into mitochondria. Both of these molecules display bioactivity in mammalian cells as well. Overall, MitoBloCK-1 and MitoBloCK-3 illustrate the value of chemical genetic tools to extend studies of protein translocation in yeast to mammalian models such as zebrafish, cultured cells, and mouse.